Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Stake Lifted by Inspire Investing LLC

Inspire Investing LLC increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 54.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,249 shares of the company’s stock after purchasing an additional 3,602 shares during the period. Inspire Investing LLC’s holdings in Acadia Healthcare were worth $406,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ACHC. GAMMA Investing LLC raised its holdings in Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after buying an additional 241 shares during the period. Nisa Investment Advisors LLC increased its position in shares of Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after acquiring an additional 301 shares in the last quarter. Atria Investments Inc raised its holdings in shares of Acadia Healthcare by 4.7% during the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after acquiring an additional 308 shares during the period. KBC Group NV lifted its position in shares of Acadia Healthcare by 14.4% in the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after acquiring an additional 338 shares in the last quarter. Finally, Tidal Investments LLC grew its position in Acadia Healthcare by 7.9% during the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after purchasing an additional 340 shares in the last quarter.

Acadia Healthcare Price Performance

Shares of ACHC opened at $44.18 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market cap of $4.10 billion, a PE ratio of 14.49, a PEG ratio of 1.79 and a beta of 1.29. Acadia Healthcare Company, Inc. has a twelve month low of $36.50 and a twelve month high of $87.77. The firm’s 50 day moving average price is $41.15 and its 200 day moving average price is $56.37.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 EPS. As a group, research analysts expect that Acadia Healthcare Company, Inc. will post 3.39 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ACHC. Cantor Fitzgerald restated a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. TD Cowen reduced their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $64.00 target price on shares of Acadia Healthcare in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Finally, Barclays lowered their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.